CyVek Receives $5,500,000 Series D Funding

  • Feed Type
  • Date
  • Company Name
  • Mailing Address
    2 Barnes Industrial Road South Wallingford, CT 06492
  • Company Description
    The objective of the CyVek technology is to provide a robust platform for multiplexed proteomics, particularly to serve the market needs of biomarker validation.
  • Website
  • Transaction Type
    Venture Equity
  • Transaction Amount
  • Transaction Round
    Series D
  • Proceeds Purposes
    The Series D funding enables the company to create the infrastructure needed to commercialize its novel immunoassay technology, CyPlex(TM), an integrated test system which includes a proprietary microfluidic cartridge that allows the analysis of multiple biomarkers from very small amounts of biological samples.
  • M&A Terms
  • Venture Investor
    Connecticut Innovations
  • Venture Investor

Trending on Xconomy